Patients who are overweight when they're first diagnosed with cancer may be at higher risk of developing a second cancer.

Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure ...

Severe obesity is already a significant problem for many children, especially since obese children often become obese adults.

Obese children as young as six could receive Ozempic-style weight-loss jabs after a “promising” first trial. Slimming ...

Weight-loss jabs could soon be offered to children as young as six after a study found they safely helped obese youngsters ...

The researchers found that a higher BMI in both women and men was associated with lower fertility, meaning it took longer for those couples to get pregnant. In general, the higher the BMI, the longer ...

About 40% of Louisiana adults are obese, according to new data released by the Centers for Disease Control and Prevention.

Novo Nordisk announced Phase 2a trial results for monlunabant. The trial demonstrated a weight reduction of 7.1 kg with a 10 ...

Excess weight linked to health issues; GLP-1 agonists show promise for weight loss in non-diabetic individuals.

Semaglutide may be an effective treatment for the skin condition hidradenitis suppurative, common in people with obesity, say ...

Novo Nordisk A/S's shares have stalled recently, but this looks like a natural digestion of gains from prior years. Click for ...